157 related articles for article (PubMed ID: 17998765)
1. Drug-eluting stent implantation could be associated with long-term coronary endothelial dysfunction.
Shin DI; Kim PJ; Seung KB; Kim DB; Kim MJ; Chang K; Lim SM; Jeon DS; Chung WS; Baek SH; Lee MY
Int Heart J; 2007 Sep; 48(5):553-67. PubMed ID: 17998765
[TBL] [Abstract][Full Text] [Related]
2. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent.
Kim JW; Suh SY; Choi CU; Na JO; Kim EJ; Rha SW; Park CG; Seo HS; Oh DJ
JACC Cardiovasc Interv; 2008 Feb; 1(1):65-71. PubMed ID: 19393147
[TBL] [Abstract][Full Text] [Related]
3. Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.
Di Lorenzo E; Sauro R; Varricchio A; Carbone G; Cortese G; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G; De Luca G
Circulation; 2009 Sep; 120(11):964-72. PubMed ID: 19720939
[TBL] [Abstract][Full Text] [Related]
4. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.
Clever YP; Cremers B; Speck U; Dietz U; Böhm M; Scheller B
Catheter Cardiovasc Interv; 2014 Aug; 84(2):323-31. PubMed ID: 23996969
[TBL] [Abstract][Full Text] [Related]
5. Specific coronary drug-eluting stents interfere with distal microvascular function after single stent implantation in pigs.
van den Heuvel M; Sorop O; Batenburg WW; Bakker CL; de Vries R; Koopmans SJ; van Beusekom HM; Duncker DJ; Danser AH; van der Giessen WJ
JACC Cardiovasc Interv; 2010 Jul; 3(7):723-30. PubMed ID: 20650434
[TBL] [Abstract][Full Text] [Related]
6. A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus.
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Kim HS; Park SJ
J Am Coll Cardiol; 2008 Aug; 52(9):727-33. PubMed ID: 18718419
[TBL] [Abstract][Full Text] [Related]
7. Long-term coronary endothelial function after zotarolimus-eluting stent implantation. A 9 month comparison between zotarolimus-eluting and sirolimus-eluting stents.
Shin DI; Seung KB; Kim PJ; Chang K; Choi JK; Jeon DS; Kim MJ; Lee MY; Chung WS
Int Heart J; 2008 Nov; 49(6):639-52. PubMed ID: 19075480
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction.
Togni M; Windecker S; Cocchia R; Wenaweser P; Cook S; Billinger M; Meier B; Hess OM
J Am Coll Cardiol; 2005 Jul; 46(2):231-6. PubMed ID: 16022947
[TBL] [Abstract][Full Text] [Related]
9. Head-to-head comparison of sirolimus-eluting stent versus bare metal stent evaluation of the coronary endothelial dysfunction in the same patient presenting with multiple coronary artery lesions: the CREDENTIAL study.
Mischie AN; Nazzaro MS; Fiorilli R; De Felice F; Musto C; Confessore P; Parma A; Boschetti C; Violini R
Catheter Cardiovasc Interv; 2013 Sep; 82(3):E184-91. PubMed ID: 23359371
[TBL] [Abstract][Full Text] [Related]
10. The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans.
Papafaklis MI; Bourantas CV; Theodorakis PE; Katsouras CS; Naka KK; Fotiadis DI; Michalis LK
JACC Cardiovasc Interv; 2010 Nov; 3(11):1181-9. PubMed ID: 21087755
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study.
Petronio AS; De Carlo M; Branchitta G; Papini B; Ciabatti N; Gistri R; Cortese B; Gherarducci G; Barsotti A
J Am Coll Cardiol; 2007 Feb; 49(5):539-46. PubMed ID: 17276176
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
[TBL] [Abstract][Full Text] [Related]
14. Angiographic analysis of pattern of late luminal loss in sirolimus- and paclitaxel-eluting stents.
Agostoni P; Cosgrave J; Biondi-Zoccai GG; Sangiorgi GM; Ge L; Melzi G; Corbett S; Airoldi F; Montorfano M; Chieffo A; Michev I; Carlino M; Colombo A
Am J Cardiol; 2007 Mar; 99(5):593-8. PubMed ID: 17317355
[TBL] [Abstract][Full Text] [Related]
15. Prospective randomized comparison of sirolimus- versus paclitaxel-eluting stents for the treatment of acute ST-elevation myocardial infarction: pROSIT trial.
Lee JH; Kim HS; Lee SW; Park JH; Choi SW; Jeong JO; Cho Y; Lee N; Rhee KS; Ko JK; Seong IW
Catheter Cardiovasc Interv; 2008 Jul; 72(1):25-32. PubMed ID: 18412270
[TBL] [Abstract][Full Text] [Related]
16. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial.
Di Lorenzo E; De Luca G; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G
JACC Cardiovasc Interv; 2009 Jun; 2(6):515-23. PubMed ID: 19539255
[TBL] [Abstract][Full Text] [Related]
17. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction.
Obata JE; Kitta Y; Takano H; Kodama Y; Nakamura T; Mende A; Kawabata K; Saitoh Y; Fujioka D; Kobayashi T; Yano T; Kugiyama K
J Am Coll Cardiol; 2007 Oct; 50(14):1305-9. PubMed ID: 17903627
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.
Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ
Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247
[TBL] [Abstract][Full Text] [Related]
20. Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.
Barlis P; Kaplan S; Dimopoulos K; Ferrante G; Di Mario C
Cardiology; 2008; 111(4):270-6. PubMed ID: 18451644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
